Protagenic Therapeutics, Inc.\new Annual Nonoperating Income (Expense) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Protagenic Therapeutics, Inc.\new quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2023.
  • Protagenic Therapeutics, Inc.\new Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $11.3K, a 67.8% decline year-over-year.
  • Protagenic Therapeutics, Inc.\new Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$378K, a 943% decline year-over-year.
  • Protagenic Therapeutics, Inc.\new annual Nonoperating Income (Expense) for 2023 was -$474K, a 20841% decline from 2022.
  • Protagenic Therapeutics, Inc.\new annual Nonoperating Income (Expense) for 2022 was $2.28K.
  • Protagenic Therapeutics, Inc.\new annual Nonoperating Income (Expense) for 2021 was -$383K, a 13400% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$474K -$476K -20841% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-05-14
2022 $2.28K +$385K Jan 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
2021 -$383K -$385K -13400% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $2.88K -$332K -99.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-07
2019 $335K +$579K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 -$243K -$349K -330% Jan 1, 2018 Dec 31, 2018 10-K 2020-04-29
2017 $106K +$148K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 -$42.3K -$43.9K -2719% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $1.62K +$12K Jan 1, 2015 Dec 31, 2015 10-K/A 2017-05-08
2014 -$10.4K Jan 1, 2014 Dec 31, 2014 8-K/A 2016-07-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.